AUPH vs UHS · P/E 28, rev $160.9M vs P/E 5.9, rev $9.13B
Aurinia Pharmaceuticals Inc (AUPH) versus Universal Health Services Inc (UHS) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
Universal Health Services Inc (UHS) is a medical care facilities company listed on NYSE.
Latest reported AUPH revenue for 2026-06-30 was $160.9M. Net income was $71.8M. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Latest reported UHS revenue for 2026-06-30 was $9.13B. Net income was $707.1M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
Not investment advice. Open the AUPH and UHS stock pages for the full models.
Not investment advice.